(a) Changes in the scope of control of substances Chair: We resume considerations of Item 5, especially item 5.a. CND is called to perform its treaty mandated function related to scheduling. CND Secretariat: Pre-session documentation is available online. Including scheduling recommendations by the WHO-ECDD. Chair: First, we’ll consider scheduling recommendations on substances under 1961, then …
From Plenary Sessions
Plenary Item 3. General debate
Vietnam: We’re concerned by the threat of the drugs problem globally during the impact of COVID pandemic. NPS pose new challenges for control. Threatening security, health and happiness; especially young people. Comprehensive measures are needed at all levels. Based on experiences, scientific foundations and international cooperation. Vietnam welcomes the participation of all stakeholders dealing with …
Plenary Item 6. Follow-up to the implementation at the national, regional and international levels of all commitments, as reflected in the Ministerial Declaration of 2019, to address and counter the world drug problem (continued)
Chair: ‘Taking stock’ section of the Ministerial Declaration of 2019 specifies tangible achievements but also needs moving forward. Thematic discussions followed to address these. The most recent ones, in 2021, in October, were held in a hybrid format. Focus on: a. Thematic session 1: Increasing links between drug trafficking, corruption and other forms of organized …
Plenary Item 5. Implementation of the international drug control treaties (continued)
(d) International cooperation to ensure the availability of narcotic drugs and psychotropic substances for medical and scientific purposes while preventing their diversion Russian Federation: Access is ensured systemically. Control whilst preventing diversion in compliance with Conventions and recommendations of INCB. Patient registers, including paediatric to ensure access and safety. If a registered drug is unavailable …
Plenary Item 5. Implementation of the international drug control treaties (continued) (Night Session)
Item 5 (d). International cooperation to ensure the availability of narcotic drugs and psychotropic substances for medical and scientific purposes while preventing their diversion CHAIR: Introduction to Item 5d. We offer the framework to scale and improve the availability of narcotic drugs and psychotropic substances for medical and scientific purposes. This issue is very important to my home …
Plenary Item 4. Strategic management, budgetary and administrative questions (continued)
(a) Work of the standing open-ended intergovernmental working group on improving the governance and financial situation of the United Nations Office on Drugs and Crime CND Chair: Let me clarify what is the vote. The vote is to decide that we don’t take action on the designation of the EEG representative to FINGOV. Only the …